Results 121 to 130 of about 47,001 (202)

Noninvasive Gas Exchange Determinants of Exercise Hemodynamics in Non-Severe Pulmonary Hypertension Associated With Interstitial Lung Disease. [PDF]

Pulm Circ
Dagher C, Moallem N, Fiscus G, Carollo B, Swanson K, Farber HW, Parikh R.   +6 more
europepmc   +1 more source

New Paradigms of Cancer Require New Language: A Qualitative Study Exploring Language for Non-Curative Non-Palliative Cancer Surgery. [PDF]

J Surg Oncol
Wong BO, Farber ON, Reich AJ, Cooper ZR, Mack JW, Clancy TE, Raut CP, Lilley EJ.   +7 more
europepmc   +1 more source

Presenting features and outcomes to standard systemic therapies in patients with MTAP-deleted advanced non-small cell lung cancer. [PDF]

Clin Cancer Res
Huang J, Aldea M, Miller KW, Rotow JK, Mazzola E, Nishino M, Sholl LM, Jänne PA, Barbie DA, Shaw AT, Kehl KL, Luo J.   +11 more
europepmc   +1 more source

The patient behind the tumour: Host-related factors as determinants of immunotherapy efficacy in advanced cSCC. [PDF]

J Eur Acad Dermatol Venereol
Ruiz ES, Silk AW.
europepmc   +1 more source

Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial. [PDF]

Clin Cancer Res
Waks AG, Segui E, Li T, Lipsyc-Sharf M, Kallfelz E, DiLullo M, Patel A, Rahman T, Junkins K, Rahee H, Frey AM, Kelly E, Stalteri M, Wrabel E, Williams A, Parsons HA, Poorvu PD, Partridge AH, Abravanel DL, Poorvu N, LeStage B, Sicinski P, Tolaney SM, Wagle N, Tayob N, Shapiro GI.   +25 more
europepmc   +1 more source

Trending ileal microbiome dysbiosis over time as an early assessment of intestinal transplant rejection risk. [PDF]

Am J Transplant
Hong JS, Shamim A, Atta H, Merl S, Park H, Eliby D, Tillman A, Tekal M, Patwardhan S, Chauhan I, Jordache P, Chen B, Almesallmy A, Gunes ME, Manell E, Shen B, Dionigi B, Kiran RP, Wells SB, Farber DL, Fu J, Kato T, Martinez M, Cheung YK, Uhlemann AC, Weiner J.   +25 more
europepmc   +1 more source

Allogeneic HSCT outcomes and impact of defibrotide prophylaxis on SOS after inotuzumab in pediatric B-ALL. [PDF]

Blood Adv
Paolino JD, Hebert K, Yang J, Duncan CN, Margossian SP, Lehmann LE, Kapadia M, Whangbo JS, Takahashi T, Keating AK, Calderon FA, Horan JT, Burns MA, Davies K, Degar B, Vrooman LM, Kesselheim J, Feraco AM, Pikman Y, Place AE, Pollard JA, Silverman LB, Kean LS, Neuberg DS, Baumeister SHC.   +24 more
europepmc   +1 more source

An Abbreviated Assessment Tool for Detection of Pulmonary Hypertension in Patients With Interstitial Lung Disease. [PDF]

Pulm Circ
Dagher C, O'Sullivan DM, Farber HW, Parikh R.   +3 more
europepmc   +1 more source

Blinatumomab administration in the outpatient setting: Safety and health care utilization. [PDF]

Cancer
Valtis YK, Frost BF, Nemirovsky D, Derkach A, Chin KK, Salman MY, Boussi L, Ovalle NT, Baxter E, Mercurio A, Stein EM, Geyer MB, Schrag D, Kelkar AH, DeAngelo DJ, Luskin MR, Park JH, Chen EC.   +17 more
europepmc   +1 more source

Scalp cooling outcomes in patients receiving trastuzumab deruxtecan for metastatic breast cancer. [PDF]

ESMO Open
Salehi E, Chu X, Mayer EL, Singer S, Augdahl G, Stalteri M, Li T, Dibble KE, Sinclair N, Faggen M, Walsh J, Sammons S, Sendrick K, Hanna S, Mostaghimi A, Tayob N, LeBoeuf NR, Tolaney SM.   +17 more
europepmc   +1 more source